EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma

Clara Martínez-Vila, Cristina Teixido iD, Francisco Aya iD, Roberto Martín, Europa Azucena González-Navarro, Llucia Alos iD, Natalia Castrejon iD, Ana Arance iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26020861 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Clara Martínez-Vila und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Althaia Xarxa Assistencial Universitària de Manresa, Dr. Joan Soler, 1-3, 08243 Manresa, Spain. Hauptthemen laut MEDLINE: Melanoma, Circulating Tumor DNA, Biomarkers, Tumor. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment landscape for advanced melanoma has transformed significantly with the advent of BRAF and MEK inhibitors (BRAF/MEKi) targeting BRAFV600 mutations, as well as immune checkpoint inhibitors (ICI) like anti-PD-1 monotherapy or its combinations with anti-CTLA-4 or anti-LAG-3. Despite that, many patients still do not benefit from these treatments at all or develop resistance mechanisms. Therefore, prognostic and predictive biomarkers are needed to identify patients who should switch or escalate their treatment strategies or initiate an intensive follow-up. In melanoma, liquid biopsy has shown promising results, with a potential role in predicting relapse in resected high-risk patients or in disease monitoring during the treatment of advanced disease. Several components in peripheral blood have been analyzed, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), and circulant tumoral DNA (ctDNA), which have turned out to be particularly promising. To analyze ctDNA in blood, different techniques have proven to be useful, including digital droplet polymerase chain reaction (ddPCR) to detect specific mutations and, more recently, next-generation sequencing (NGS) techniques, which allow analyzing a broader repertoire of the mutation landscape of each patient. In this review, our goal is to update the current understanding of liquid biopsy, focusing on the use of ctDNA as a biological material in the daily clinical management of melanoma patients, in particular those with advanced disease treated with ICI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaCirculating Tumor DNABiomarkers, TumorHumansLiquid BiopsyNeoplastic Cells, CirculatingMutationHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

ICIbiomarkerctDNAdisease monitoringmelanomamutational landscape

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Althaia Xarxa Assistencial Universitària de Manresa, Dr. Joan Soler, 1-3, 08243 Manresa, Spain.
  • Programa de Doctorat en Medicina i Recerca Translacional, Facultat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain.
  • Institut de Recerca i Innovació en Ciències de la Vida i de la Salut a la Catalunya Central (IRIS-CC), Roda 70, 08500 Vic, Spain.
  • Department of Pathology, Hospital Clínic of Barcelona, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.
  • August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Rosselló 149, 08036 Barcelona, Spain.
  • Department of Medical Oncology, Hospital Clínic of Barcelona, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain.

ORCID-Profile: Cristina Teixido, Francisco Aya, Llucia Alos, Natalia Castrejon, Ana Arance

Zitieren

APA

Martínez-Vila, C., Teixido, C., Aya, F., Martín, R., González-Navarro, E. A., Alos, L., Castrejon, N., & Arance, A. (2025). Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020861

Vancouver

Martínez-Vila C, Teixido C, Aya F, Martín R, González-Navarro EA, Alos L, et al. Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020861

BibTeX
@article{MartnezVila2025,
  author = {Martínez-Vila, Clara and Teixido, Cristina and Aya, Francisco and Martín, Roberto and González-Navarro, Europa Azucena and Alos, Llucia and Castrejon, Natalia and Arance, Ana},
  title = {Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26020861}
}
Kostenlos starten →